ID

20198

Beskrivning

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies; ODM derived from: https://clinicaltrials.gov/show/NCT00441337

Länk

https://clinicaltrials.gov/show/NCT00441337

Nyckelord

  1. 2017-02-11 2017-02-11 -
Uppladdad den

11 februari 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Carcinoma, Non-Small-Cell Lung NCT00441337

Eligibility Carcinoma, Non-Small-Cell Lung NCT00441337

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
relapsed/refractory non-small cell lung cancer, colorectal adenocarcinoma, malignant melanoma, renal (clear) cell carcinoma, or hormone-refractory prostate adenocarcinoma
Beskrivning

Malignancy

Datatyp

boolean

Alias
UMLS CUI [1]
C0006826
prior treatment must have been completed at least 4 weeks prior to enrollment
Beskrivning

Prior treatment

Datatyp

boolean

Alias
UMLS CUI [1]
C1514463
no untreated primary or metastatic brain or meningeal tumors
Beskrivning

Primary or metastatic brain or meningeal tumors

Datatyp

boolean

Alias
UMLS CUI [1]
C0750974
UMLS CUI [2]
C0220650
UMLS CUI [3]
C0025284
ecog ps 0 or 1
Beskrivning

ECOG

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
meet all screening laboratory values
Beskrivning

Laboratory values

Datatyp

boolean

Alias
UMLS CUI [1]
C0022885
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of severe hypersensitivity reactions to other monoclonal antibodies
Beskrivning

Hypersensitivity to monoclonal antibodies

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3542957
active autoimmune disease or a documented history of autoimmune disease
Beskrivning

Autoimmune disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0004364
prior therapy with an anti-pd-1 or anti-ctla-4 antibody
Beskrivning

Anti-pd-1 or anti-ctla-4 antibody

Datatyp

boolean

Alias
UMLS CUI [1]
C4053601
UMLS CUI [2]
C2986402
active infection
Beskrivning

Active infection

Datatyp

boolean

Alias
UMLS CUI [1]
C0009450
concurrent medical condition requiring the use of immunosuppressive medications
Beskrivning

Immunosuppressive medications

Datatyp

boolean

Alias
UMLS CUI [1]
C0021081

Similar models

Eligibility Carcinoma, Non-Small-Cell Lung NCT00441337

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Malignancy
Item
relapsed/refractory non-small cell lung cancer, colorectal adenocarcinoma, malignant melanoma, renal (clear) cell carcinoma, or hormone-refractory prostate adenocarcinoma
boolean
C0006826 (UMLS CUI [1])
Prior treatment
Item
prior treatment must have been completed at least 4 weeks prior to enrollment
boolean
C1514463 (UMLS CUI [1])
Primary or metastatic brain or meningeal tumors
Item
no untreated primary or metastatic brain or meningeal tumors
boolean
C0750974 (UMLS CUI [1])
C0220650 (UMLS CUI [2])
C0025284 (UMLS CUI [3])
ECOG
Item
ecog ps 0 or 1
boolean
C1520224 (UMLS CUI [1])
Laboratory values
Item
meet all screening laboratory values
boolean
C0022885 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity to monoclonal antibodies
Item
history of severe hypersensitivity reactions to other monoclonal antibodies
boolean
C0020517 (UMLS CUI [1,1])
C3542957 (UMLS CUI [1,2])
Autoimmune disease
Item
active autoimmune disease or a documented history of autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Anti-pd-1 or anti-ctla-4 antibody
Item
prior therapy with an anti-pd-1 or anti-ctla-4 antibody
boolean
C4053601 (UMLS CUI [1])
C2986402 (UMLS CUI [2])
Active infection
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Immunosuppressive medications
Item
concurrent medical condition requiring the use of immunosuppressive medications
boolean
C0021081 (UMLS CUI [1])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial